Bio Nano Consulting, a spin-off of Imperial College London and University College London, has developed a device that may soon be used by clinicians to measure the amount of protein in urine. This may turn out to be a new way to test for kidney disease at the point of care, a process which currently requires a clinical lab.
The device is a quantitative electrochemical lateral flow assay (QELFA), essentially a modification of at-home pregnancy tests. It’s quite tiny and has an even tinier readout screen that shows the concentration of protein and it sounds like there’s a wireless chip inside to quickly send the results to a hospital electronic medical record system.
The company just won the Smart Award from Innovate UK that will help finalize the development and testing of the device.
Source: Bio Nano
(hat tip: The Engineer)